← FDA Drug Approvals (Drugs@FDA)

RUXOLITINIB

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TORRENT PHARMACEUTICALS LTD · Approved 2026-03-23

Drug application

FDA Application #

ANDA220375

Application type

Abbreviated New Drug Application (Generic)

Brand name

RUXOLITINIB

Generic name

Ruxolitinib

Active ingredients

RUXOLITINIB

Dosage form

TABLET

Route

—

Marketing status

None (Tentative Approval)

Sponsor

TORRENT PHARMACEUTICALS LTD

First approval

2026-03-23

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown